XML 161 R44.htm IDEA: XBRL DOCUMENT
v3.25.1

Stock Options and Award Programs (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Stock Options and Award Programs |
Schedule of assumptions |
|  | YEARS ENDED |
|  | DECEMBER 31, |
|  | 2024 |  |  | 2023 |
Stock options granted |  |  | - |  |  |  | 288,570 |
Expected dividend yield |  |  | - |  |  |  | - |
Expected volatility |  |  | - |  |  | 61.6% - 62.2% |
Risk-free interest rate |  |  | - |  |  |  | 4.1 | %
Term |  |  | - |  |  | 4 years |
Schedule of non qualified stock option awards |
|  | 2024 |  |  | 2023 |
|  |  |  |  | Weighted |  |  |  |  |  | Weighted |
|  |  |  |  | Average |  |  |  |  |  | Average |
|  |  |  |  | Grant Date |  |  |  |  |  | Grant Date |
NON-VESTED OPTIONS |  | Shares |  |  | Fair Value |  |  | Shares |  |  | Fair Value |
Non-vested balances, January 1, |  |  | 288,570 |  |  | $ | 0.91 |  |  |  | - |  |  |  | - |
Granted (+) |  |  | - |  |  |  | - |  |  |  | 288,570 |  |  | $ | 0.91 |
Expired (-) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Vested/Excercised (-) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Non-vested balances, December 31, |  |  | 288,570 |  |  | $ | 0.91 |  |  |  | 288,570 |  |  | $ | 0.91 |
|  | 2024 |  |  | 2023 |
|  |  |  |  | Weighted |  |  |  |  |  | Weighted |
|  |  |  |  | Average |  |  |  |  |  | Average |
OUTSTANDING AND EXERCISABLE OPTIONS |  | Shares |  |  | Exercise Price |  |  | Shares |  |  | Exercise Price |
Awards outstanding, January 1, |  |  | 288,570 |  |  | $ | 2.04 |  |  |  | 7,500 |  |  | $ | 4.90 |
Granted (+) |  |  | - |  |  |  | - |  |  |  | 288,570 |  |  | $ | 2.04 |
Cancelled (-) |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Expired (-) |  |  | - |  |  |  | - |  |  |  | 7,500 |  |  | $ | 4.90 |
Awards outstanding, December 31, |  |  | 288,570 |  |  | $ | 2.04 |  |  |  | 288,570 |  |  | $ | 2.04 |
Awards vested and expected to vest, |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
December 31, |  |  | 285,923 |  |  | $ | 2.04 |  |  |  | 285,923 |  |  | $ | 2.04 |
Awards outstanding and exercisable, |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
December 31, |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Schedule of weighted-average remaining contractual life and the aggregate intrinsic value |
|  |  |  |  |  |  |  | Outstanding |
|  |  |  |  | Expected to |  |  | and |
|  | Outstanding |  |  | Vest |  |  | Exercisable |
Weighted-average remaining contractual life (in years) |  |  | 3.73 |  |  |  | 3.73 |  |  |  | - |
Aggregate intrinsic value |  | $ | 806,681 |  |  | $ | 799,282 |  |  | $ | - |
Schedule of restricted stock awards |
|  | 2024 |  |  | 2023 |
VESTED AND NON-VESTED AWARDS |  |  |  |  |  |
Non-vested awards outstanding, January 1, |  |  | 615,992 |  |  |  | 188,903 |
Granted (+) |  |  | 399,496 |  |  |  | 628,572 |
Cancelled (-) |  |  | - |  |  |  | 31,746 |
Vested (-) |  |  | 692,468 |  |  |  | 169,737 |
Non-vested awards outstanding, December 31, |  |  | 323,020 |  |  |  | 615,992 |
Weighted-average remaining contractual life (in years) |  |  | 1.1 |  |  |  | 0.3 |
Unamortized RSA compensation expense |  | $ | 558,518 |  |  | $ | 483,416 |
Aggregate intrinsic value of RSAs non-vested, December 31 |  | $ | 1,563,417 |  |  | $ | 1,429,101 |
Aggregate intrinsic value of RSAs vested, December 31 |  | $ | 1,833,635 |  |  | $ | 326,628 |
Schedule of share-based compensation expense |
|  | YEAR ENDED DECEMBER 31, 2024 |  |  | YEAR ENDED DECEMBER 31, 2023 |
|  | Shared-Based Compensation Expense |  |  | Shared-Based Compensation Expense |
|  | Employees |  |  | Directors |  |  | Total |  |  | Employees |  |  | Directors |  |  | Total |
Restricted share-based compensation expense |  | $ | 852,168 |  |  | $ | 244,894 |  |  | $ | 1,097,062 |  |  | $ | 641,730 |  |  | $ | 272,464 |  |  | $ | 914,194 |
Non-qualified option share-based compensation expense |  |  | 114,185 |  |  |  | - |  |  |  | 114,185 |  |  |  | 46,797 |  |  |  | - |  |  |  | 46,797 |
Total share-based compensation before taxes |  | $ | 966,353 |  |  | $ | 244,894 |  |  | $ | 1,211,247 |  |  | $ | 688,527 |  |  | $ | 272,464 |  |  | $ | 960,991 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | wyy_ScheduleOfRestrictedStockAwardsVestedAndNonVestedAwards
Namespace Prefix: | wyy_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | wyy_ScheduleOfWeightedAverageRemainingContractualLifeAndTheAggregateIntrinsicValueTableTextBlock
Namespace Prefix: | wyy_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration